U.S. firm targets costly drugs
A small Texas-based health-claims processor has opened a crucial new front in the war over whether Americans should be allowed to import lower-cost prescription drugs from Canada. The outfit, SPC
A small Texas-based health-claims processor has opened a crucial new front in the war over whether Americans should be allowed to import lower-cost prescription drugs from Canada. The outfit, SPC